antibody therapy for prostate cancer n.
Skip this Video
Loading SlideShow in 5 Seconds..
GFP antibody PowerPoint Presentation
Download Presentation
GFP antibody

GFP antibody

19 Vues Download Presentation
Télécharger la présentation

GFP antibody

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Antibody Therapy For Prostate Cancer Researchers in the US led pre lit by Doctor Mark Greene of the University of Pennsylvania School of Medication have developed a monoclonal antibody that they wish will become a successful therapeutic agent against prostatic cancer. Each year thousands of men die from extreme kinds of this disease. This kind of research holds out wish for those damaged though it will be some time before clinical trials will be performed. GFP antibody When we become infected by overseas cells such as bacterias or viruses or cancers cells one very important means of defense that people can utilize is to generate antibodies. All cells have proteins on their floors known as antigens. When ever foreign cells enter our bodies the antigens are recognized as foreign by our immune system and B Lymphocytes are encouraged to produce antibodies. When antibodies are formed they act by attaching and binding to the antigens on the surface of the invading cell. This kind of finally causes the break down of the cell and the removal of the infection or cancer skin cells. Antibodies are a really powerful weapon in our combat against disease. There are two significant characteristics of antibodies that we can exploit in the treatment of disease. One is that antibodies are totally specific. For example if we contract contamination such as rubella we will produce an antibody specifically targeted to the rubella virus. The second feature is the fact antibodies remain in our physiques after an infection has been cleared thereby conferring protection ahead6171 against that disease. It can be these characteristics that contain resulted in the development of vaccine technology. Pharmaceutical drug companies take pathological microorganisms and treat them so they cannot cause infection. These types of inactive organisms make up the key component of a vaccine. If a vaccine is administered our immune system recognizes the antigen, antibody is produced and that we become immune to future illness. The cells which produce antibodies are B Lymphocytes, which are white bloodstream cells. Scientists can separate and clone B lymphocytes to produce antibodies in laboratory conditions. These antibodies then can be used therapeutically to treat disease or cancer. The antibodies produced will be either polyclonal or monoclonal. Polyclonal antibodies are produced from several cell lines. Monoclonal antibodies are produced from just one cell collection. To produce a monoclonal antibody a B Lymphocyte is fused with a tumor cell. The joined cell is known as a hybridoma and it includes the capability of recreating endlessly. This technology allows scientists to create infinite and large quantities of very specific

  2. antibody which is often used to treat disease very effectively. One of the major features of the use of monoclonal antibodies is its absolute specificity. It targets a malignancy cell directly with few side effects for the individual.